Department of Medicine, SOVAH Health, Danville, Virginia, USA.
Department of Medicine, Division of Cardiology, Veteran Affairs Boston Healthcare System, Boston, Massachusetts, USA.
Diabet Med. 2022 Jul;39(7):e14857. doi: 10.1111/dme.14857. Epub 2022 May 3.
We evaluated the associations of heart rate variability (HRV) with incident vision-threatening retinopathy and retinopathy progression among adults with type 2 diabetes.
Participants recruited to the ACCORD (Action to Control Cardiovascular Risk in Diabetes) study with HRV measures at baseline were analysed. HRV measures included standard deviation of all normal-to-normal intervals (SDNN) and root mean square of successive differences between normal-to-normal intervals (rMSSD). Low SDNN was defined as SDNN <8.2 ms; low rMSSD as rMSSD <8.0 ms. We used multivariable adjusted Cox proportional hazards and modified Poisson regression models to generate risk estimates for incident vision-threatening retinopathy and retinopathy progression, respectively.
A total of 5810 participants without incident vision-threatening retinopathy at baseline (mean age 62 years, 40.5% women, 63.5% White) were included. Over a median of 4.7 years, 280 incident vision-threatening retinopathy cases requiring treatment occurred. Low HRV (vs. normal HRV) was associated with higher risk of incident vision-threatening retinopathy (adjusted hazard ratio 1.32 [95%CI 1.03-1.71] and 1.14 [95%CI 1.01-1.28] for low SDNN and rMSSD, respectively). In the subset of 2184 participants with complete eye examinations at baseline and 4 years, 191 experienced retinopathy progression, and low HRV (vs. normal HRV) was associated with a higher risk of retinopathy progression (adjusted relative risks 1.36 [95%CI 1.01-1.83] and 1.36 [95%CI 1.01-1.84] for low SDNN and rMSSD, respectively).
Cardiac autonomic neuropathy, as assessed by low HRV, was independently associated with increased risks of incident vision-threatening retinopathy and overall retinopathy progression in a large cohort of adults with type 2 diabetes.
我们评估了心率变异性(HRV)与 2 型糖尿病成人新发威胁视力的视网膜病变和视网膜病变进展的相关性。
对 ACCORD(控制心血管风险的行动)研究中基线时具有 HRV 测量值的参与者进行分析。HRV 测量值包括所有正常-正常间隔的标准差(SDNN)和正常-正常间隔之间连续差异的均方根(rMSSD)。低 SDNN 定义为 SDNN <8.2ms;低 rMSSD 定义为 rMSSD <8.0ms。我们使用多变量调整的 Cox 比例风险和改良泊松回归模型,分别生成新发威胁视力的视网膜病变和视网膜病变进展的风险估计值。
共纳入 5810 名基线时无新发威胁视力的视网膜病变患者(平均年龄 62 岁,40.5%为女性,63.5%为白人)。在中位时间为 4.7 年的随访中,发生了 280 例需要治疗的新发威胁视力的视网膜病变病例。与正常 HRV 相比,低 HRV(低 SDNN 和 rMSSD 分别为 1.32[95%CI 1.03-1.71]和 1.14[95%CI 1.01-1.28])与新发威胁视力的视网膜病变风险增加相关。在基线和 4 年时有完整眼部检查的 2184 名参与者亚组中,有 191 人发生了视网膜病变进展,与正常 HRV 相比,低 HRV(低 SDNN 和 rMSSD 分别为 1.36[95%CI 1.01-1.83]和 1.36[95%CI 1.01-1.84])与视网膜病变进展风险增加相关。
在 2 型糖尿病的大型队列中,心脏自主神经病变(通过低 HRV 评估)与新发威胁视力的视网膜病变和整体视网膜病变进展的风险增加独立相关。